You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

international Prognostic Scoring System (IPSS) low

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

MDS Trial in Worldwide (Oral Azacitidine, Placebo for Oral Azacitidine)

Not yet recruiting
  • Myelodysplastic Syndromes
  • Oral Azacitidine
  • Placebo for Oral Azacitidine
  • Buenos Aires, Argentina
  • +1 more
Aug 1, 2022

Azacitidine in International Prognostic Scoring System

Recruiting
  • Myelodysplastic Syndromes
  • +2 more
    • Hefei, Anhui, China
    • +16 more
    Sep 6, 2022

    MDS Trial in Worldwide (Luspatercept, Epoetin Alfa)

    Not yet recruiting
    • Myelodysplastic Syndromes
    • Luspatercept
    • Epoetin Alfa
    • Concord, California
    • +100 more
    Jul 20, 2023

    MDS and Allogeneic Stem Cell Transplantation Trial in Perugia (MDS and AlloHSCT)

    Recruiting
    • MDS and Allogeneic Stem Cell Transplantation
    • MDS and AlloHSCT
    • Perugia, PG, Italy
      University of Perugia
    Mar 11, 2021

    Primary Myelofibrosis Trial in Japan (Fedratinib)

    Recruiting
    • Primary Myelofibrosis
    • Suwa, Nagano, Japan
    • +25 more
    Jan 18, 2023

    MDS Trial in France, Germany, United States (Oral rigosertib)

    Completed
    • Myelodysplastic Syndromes
    • Oral rigosertib
    • Stanford, California
    • +13 more
    Jun 15, 2021

    Myelodysplastic Syndrome Trial in Worldwide (Lenalidomide)

    Completed
    • Myelodysplastic Syndrome
    • Centre City, New Jersey
    • +148 more
    Aug 18, 2022

    MDS Trial (Imetelstat)

    Available
    • Myelodysplastic Syndromes
    • (no location specified)
    Jun 30, 2023

    MDS Trial in China, Japan (Luspatercept)

    Recruiting
    • Myelodysplastic Syndromes
    • Beijing, China
    • +33 more
    Aug 16, 2022

    MDS Trial in Worldwide (Luspatercept, Placebo)

    Completed
    Has Results
    • Myelodysplastic Syndromes
    • Stanford, California
    • +73 more
    Nov 19, 2021

    MDS Trial in Worldwide (Magrolimab, Azacitidine, Placebo)

    Active, not recruiting
    • Myelodysplastic Syndromes
    • Magrolimab
    • +2 more
    • Birmingham, Alabama
    • +168 more
    Dec 7, 2022

    MDS, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic Trial in Newcastle (Subcutaneous azacitidine, Oral

    Not yet recruiting
    • Myelodysplastic Syndromes
    • +3 more
    • Subcutaneous azacitidine
    • Oral decitabine/cedazuridine
    • Newcastle, New South Wales, Australia
      Calvary Mater Newcastle
    May 29, 2023

    GENOMED4ALL: Improving MDS Classification and Prognosis by AI

    Active, not recruiting
    • Myelodysplastic Syndromes
      • Milano, Italy
        Istituto Clinico Humanitas
      Jun 28, 2021

      Myelodysplastic Syndrome Trial in New York (rigosertib)

      Withdrawn
      • Myelodysplastic Syndrome
      • New York, New York
        Columbia University Medical Center
      Jun 29, 2020

      Anemia in MDS Trial in Plantation, Bronx, Austin (TP-0184)

      Completed
      • Anemia in Myelodysplastic Syndromes
      • Plantation, Florida
      • +2 more
      Apr 4, 2022

      MDS Trial (Decitabine/Cedazuridine, Magrolimab)

      Not yet recruiting
      • Myelodysplastic Syndromes
      • (no location specified)
      Apr 18, 2023

      MDS Trial in Miami, New York (50 gm CIVI/24 hours x 5 days every 4 week)

      Recruiting
      • Myelodysplastic Syndromes
      • 50 gm CIVI/24 hours x 5 days every 4 week
      • Miami, Florida
      • +1 more
      Jul 6, 2022

      Ovarian Cancer Individualized Scoring System Scoring System

      Not yet recruiting
      • Ovarian Cancer
        • Alexandria, Egypt
        • +1 more
        Aug 9, 2022

        MDS, CMML Trial in Florence (CC-486)

        Recruiting
        • MDS
        • CMML
        • Florence, Italy
          AOU Careggi- University of Florence
        Mar 16, 2021

        International Consensus Definition of LARS IntoBowl Dysfunction

        Recruiting
        • Low Anterior Resection Syndrome
          • Cardiff, United Kingdom
            Julie Cornish
          Oct 31, 2022

          Benign Prostatic Hyperplasia, Lower Urinary Tract Symptoms Trial (Neuflo BPH Treatment System)

          Not yet recruiting
          • Benign Prostatic Hyperplasia
          • Lower Urinary Tract Symptoms
          • Neuflo BPH Treatment System
          • (no location specified)
          May 23, 2023

          Upper GI Bleeding Trial in Sohag (history taking , vital signs and labaratory investigations)

          Recruiting
          • Upper GI Bleeding
          • history taking , vital signs and labaratory investigations
          • Sohag, Egypt
            Sohag University hospitals
          May 17, 2023

          MDS Trial (Hetrombopag)

          Not yet recruiting
          • Myelodysplastic Syndromes
          • (no location specified)
          May 23, 2022

          Philadelphia Negative Myeloproliferative Tumors Trial

          Not yet recruiting
          • Philadelphia Negative Myeloproliferative Neoplasms
            • (no location specified)
            Jun 5, 2022

            Anemia, MDS, Chronic Myelomonocytic Leukemia Trial in France, United States (Sotatercept)

            Completed
            Has Results
            • Anemia
            • +5 more
            • Denver, Colorado
            • +19 more
            Oct 20, 2022